Arrow Financial Has Trimmed By $555,672 Its Cvs Health (CVS) Holding; Sonic (SONC) Sentiment Is 0.8

June 7, 2017 - By Stephen Andrade

Sonic Corp. operates and franchises the chain of drive-thru restaurants in the United States. The company has market cap of $1.25 billion. As of August 31, 2016, 3,557 Sonic Drive-Ins were in operation from coast to coast in 45 states, consisting of 345 Company drive-thrus and 3,212 franchise drive-thrus. It has a 21.79 P/E ratio. As of August 31, 2016, its restaurant design and construction consisted of a kitchen housed in a one-story building, which was approximately 1,500 square feet, flanked by canopy-covered rows of 16 to 24 parking spaces, with each space having its own payment terminal, intercom speaker system and menu board.

Arrow Financial Corp decreased Cvs Health Corp (CVS) stake by 18.29% reported in 2016Q4 SEC filing. Arrow Financial Corp sold 7,124 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Arrow Financial Corp holds 31,820 shares with $2.51M value, down from 38,944 last quarter. Cvs Health Corp now has $78.33 billion valuation. The stock declined 0.17% or $0.13 reaching $77.76 per share. About 2.10M shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since June 7, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 4 insider sales for $1.69 million activity.

Clearline Capital Lp holds 3.35% of its portfolio in Sonic Corporation for 278,543 shares. Ranger Investment Management L.P. owns 1.09 million shares or 2.05% of their US portfolio. Moreover, Southeastern Asset Management Inc Tn has 1.19% invested in the company for 4.65 million shares. The Quebec – Canada-based Pembroke Management Ltd has invested 1.07% in the stock. Malaga Cove Capital Llc, a California-based fund reported 42,359 shares.

Analysts await Sonic Corporation (NASDAQ:SONC) to report earnings on June, 22. They expect $0.41 earnings per share, down 4.65% or $0.02 from last year’s $0.43 per share. SONC’s profit will be $17.51M for 17.85 P/E if the $0.41 EPS becomes a reality. After $0.15 actual earnings per share reported by Sonic Corporation for the previous quarter, Wall Street now forecasts 173.33% EPS growth.

About 121,980 shares traded. Sonic Corporation (SONC) has declined 5.36% since June 7, 2016 and is downtrending. It has underperformed by 22.06% the S&P500.

Since February 1, 2017, it had 0 insider buys, and 6 selling transactions for $22.09 million activity. On Thursday, February 16 Roberts Jonathan C sold $4.90 million worth of CVS Health Corp (NYSE:CVS) or 61,196 shares. 6,029 shares were sold by Boratto Eva C, worth $479,908 on Friday, March 17. Another trade for 14,104 shares valued at $1.13M was sold by Sussman Andrew. MERLO LARRY J sold $5.99M worth of stock or 76,494 shares. Denton David M sold $7.71 million worth of CVS Health Corp (NYSE:CVS) on Friday, March 10. Brennan Troyen A sold $1.88 million worth of stock or 23,849 shares.

Among 17 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. CVS Health had 27 analyst reports since July 22, 2015 according to SRatingsIntel. Mizuho maintained CVS Health Corp (NYSE:CVS) on Wednesday, November 9 with “Buy” rating. The firm has “Hold” rating given on Thursday, August 20 by Deutsche Bank. On Monday, November 2 the stock rating was maintained by Oppenheimer with “Outperform”. The company was maintained on Wednesday, August 5 by RBC Capital Markets. The stock has “Overweight” rating by JP Morgan on Monday, November 2. The firm earned “Buy” rating on Thursday, May 12 by Jefferies. The rating was maintained by Deutsche Bank with “Hold” on Wednesday, July 22. Robert W. Baird initiated the shares of CVS in report on Friday, January 22 with “Outperform” rating. The stock of CVS Health Corp (NYSE:CVS) earned “Overweight” rating by Barclays Capital on Thursday, March 10. Goldman Sachs downgraded CVS Health Corp (NYSE:CVS) on Thursday, December 17 to “Neutral” rating.

Analysts await CVS Health Corp (NYSE:CVS) to report earnings on August, 1. They expect $1.31 EPS, down 0.76% or $0.01 from last year’s $1.32 per share. CVS’s profit will be $1.32 billion for 14.84 P/E if the $1.31 EPS becomes a reality. After $1.17 actual EPS reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 11.97% EPS growth.

Investors sentiment decreased to 0.74 in Q4 2016. Its down 0.24, from 0.98 in 2016Q3. It is negative, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Boyd Watterson Asset Oh owns 5,989 shares. Trust Of Virginia Va reported 90,507 shares. Princeton Portfolio Strategies Gru Llc holds 36,611 shares or 0.91% of its portfolio. 122,360 were reported by Highland Capital Llc. 15,570 were accumulated by Pioneer Trust Bank N A Or. Andra Ap accumulated 113,000 shares or 0.24% of the stock. Sit Associate, Minnesota-based fund reported 41,114 shares. Kayne Anderson Rudnick Inv Mngmt Ltd Liability Co accumulated 0.04% or 39,199 shares. Clear Harbor Asset Limited Liability Co accumulated 6,898 shares or 0.11% of the stock. Kanawha Lc, a Virginia-based fund reported 45,508 shares. Coho Prtnrs Ltd owns 1.44 million shares for 3.98% of their portfolio. First Heartland Consultants Inc reported 0.21% of its portfolio in CVS Health Corp (NYSE:CVS). Clal Ins Enterp holds 0.03% or 20,000 shares. Adage Ptnrs Gp Ltd Liability Com stated it has 1.40 million shares. Gould Asset Management Limited Liability Company Ca stated it has 0.16% of its portfolio in CVS Health Corp (NYSE:CVS).